×
Back to Agenda
Session 2 : Orphan Drug development and Approval in Regulatory Perspective
Session Chair(s)
Jin-A Jeong
General Manager
Hanmi, United States
Speaker(s)
Clinical Pharmacology in Drug Development for Rare and Rare Pediatric
Insook Kim, PhD
United States
Orphan Drug Designation And A Regulatory Perspective
Myeong-Ah Chung
NIFDS, Korea, Republic of
Importance Of Bioanalysis In Drug Development
Chongwoo Yu, PhD
United States
Have an account?